Curcumin’s ability to modulate the MAPK-RAS-RAF-MEK-ERK pathway represents a promising mechanism for its anticancer activity by targeting multiple components of this signaling cascade, curcumin disrupts oncogenic signaling, promotes apoptosis, and inhibits cancer cell proliferation, highlighting its potential as a therapeutic agent in cancer treatment. Here, MAP2K7 is linked to cancer.